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Abtstract
Introduction: Changes of thyroid hormones levels may lead to effects, not only in ventricular function, but also atrial function. The aim 
of this study was to investigate left atrial (LA) mechanical functions, atrial electromechanical coupling and P wave dispersion in patients 
with subclinical thyroid disorders.
Material and methods: Eighty patients with subclinical thyroid disorders and forty controls were included. A diagnosis of subclinical 
thyroid disorders were reached with increased or decreased serum TSH and normal free T4 (fT4) levels. LA volumes were measured 
using the biplane area length method and LA active and passive emptying volumes and fraction were calculated. Intra- and interatrial 
electromechanical delay were measured by tissue Doppler imaging (TDI).
Results: All groups had similar demographic findings. LA mechanical functions significantly impaired in subclinical thyroid disorders than control 
group. Intra- and Interatrial delay, were measured significantly higher in patients with subclinical thyroid disorders than control group. PA lateral 
and interatrial delay were positively correlated with TSH (r = 0.507, p = 0.006 and r = 0.455, p = 0.015, respectively) in subclinical hypothyroid pa-
tients. There was negative correlation between TSH and interatrial delay (r = –0.492, p = 0.006) in subclinical hyperthyroid patients. Linear multivariate 
regression analysis demonstrated that, TSH was the only an independent factor of interatrial delay in patients with subclinical thyroid disorders.
Conclusions: This study showed that impaired LA mechanical and electromechanical function in subclinical thyroid disorders. TSH was 
an independent determinant of interatrial delay. Prolonged atrial electromechanical coupling time and impaired mechanical atrial func-
tions may be related to the increased incidence of arrhythmias. (Endokrynol Pol 2012; 63 (4): 286–293)
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Streszczenie
Wstęp: Zmiany stężeń hormonów tarczycy mogą wpływać nie tylko na czynność komór serca, ale również na czynność przedsionków. 
Niniejsze badanie przeprowadzono w celu oceny czynności mechanicznej lewego przedsionka (LA), sprzężenia elektromechanicznego 
i dyspersji załamka P u chorych z subklinicznymi zaburzeniami czynności tarczycy.
Materiał i metody: Do badania włączono 80 chorych z subklinicznymi zaburzeniami czynności tarczycy i 40 osób stanowiących grupę 
kontrolną. Zaburzenia czynności tarczycy rozpoznawano na podstawie obniżonego lub podwyższonego stężenia TSH w surowicy 
i prawidłowego stężenia wolnej T4 (fT4). Zmierzono objętości LA, posługując się dwupłaszczyznową metodą area-lenght (pole– wymiar 
podłużny). Obliczono również objętości i frakcje aktywnego i biernego opróżniania LA. Do pomiaru opóźnienia przewodnictwa wewnątrz- 
i międzyprzedsionkowego zastosowano technikę doplera tkankowego.
Wyniki: Grupy nie różniły się pod względem charakterystyki demograficznej. W grupie z zaburzeniami czynności tarczycy mechaniczna 
funkcja przedsionków była istotnie upośledzona w porównaniu z osobami z grupy kontrolnej. Opóźnienie przewodnictwa wewnątrz- 
i międzyprzedsionkowego stwierdzano istotnie częściej u osób z zaburzeniami czynności tarczycy. Stwierdzono dodatnią korelację miedzy 
opóźnieniem elektromechanicznym (PA lateral) i opóźnieniem przewodzenia międzyprzedsionkowego a TSH (odpowiednio r = 0,507; 
p = 0,006 i r = 0,455; p = 0,015) u osób z subkliniczną niedoczynnością tarczycy. Z kolei u osób z subkliniczną nadczynnością tarczycy 
zaobserwowano ujemną korelację między TSH i opóźnieniem przewodzenia międzyprzedsionkowego (r = –0,492; p = 0,006). W wie-
loczynnikowej analizie regresji liniowej wykazano, że stężenie TSH było jedynym parametrem niezależnie związanym z opóźnieniem 
przewodzenia międzyprzedsionkowego u chorych z subklinicznymi zaburzeniami czynności tarczycy.
Wnioski: W niniejszym badaniu wykazano upośledzoną czynność mechaniczną i elektromechaniczną LA u chorych z subklinicznymi 
zaburzeniami czynności tarczycy. Stężenie TSH było niezależnym czynnikiem determinującym opóźnienie przewodzenia międzyprzed-
sionkowego. Wydłużenie czasu sprzężenia elektromechanicznego i upośledzenie mechanicznej czynności przedsionków mogą się wiązać 
ze zwiększoną zapadalnością na zaburzenia rytmu. (Endokrynol Pol 2012; 63 (4): 286–293)
Słowa kluczowe: hormony tarczycy, czynność przedsionków, opóźnienie przewodzenia międzyprzedsionkowego
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Introduction
Thyroid hormone receptors are abundant in the myo-
cardium, so the heart is extremely sensitive to thyroid 
hormones [1]. There are many regulatory effects of thyroid 
hormones, such as cardiac protein transcription, gene ex-
pression [2], impaired myocardial contractility, decreased 
cardiac output, variability of heart rate, increased systemic 
vascular resistance [3], cardiomyocyte atrophy, endothelial 
dysfunctions [4, 5], higher prevalence of atherosclerosis 
and development of heart failure [6, 7]. Some clinical stud-
ies have shown that even subclinical hyperthyroidism and 
subclinical hypothyroidism were associated with changes 
in various cardiac parameters [8, 9]. Subclinical hyperthy-
roidism is related to a few elevated systolic functions and 
decreased diastolic functions due to slowed myocardial 
relaxation [1, 8, 10]. Moreover, subclinical hypothyroidism 
is associated with LV diastolic dysfunction qualified by 
slowed myocardial relaxation and disabled rapid ventricu-
lar filling, both at rest and after exercise. Frequently this is 
related to a changeable impairment in LV systolic function 
even at the very early stage [11, 12]. Therefore, subclinical 
thyroid disorders could result in significant changes in the 
cardiovascular system.
Alterations in thyroid status may lead to changes not 
only in ventricular function, but also in atrial function. In 
a study, atrial systolic time interval, atrial ejection time 
and atrial preejection period were used to evaluate atrial 
function and examine the relationship between hyperthy-
roidism and atrial function [13]. Currently, measurement of 
the left atrial (LA) size is the most commonly used method 
to estimate the amount of atrial remodelling. Left atrial 
(LA) volumes and LA mechanical functions have recently 
been identified as a potential indicator of cardiac disease 
and arrhythmias [14–16]. Intra- and interatrial conduction 
delay are well known electrophysiological phenomena 
distinguishing the atria prone to fibrillation [17]. Unlike 
LA size, atrial conduction times reflect the amount of both 
electrical and structural remodelling of the atria. Some 
authors have used left atrial sizes and atrial conduction 
time to show atrial function. All of these parameters have 
shown similar and correlated results for impaired atrial 
function [17–19]. However, LA mechanical functions and 
atrial conduction abnormalities have not been investigated 
in subclinical thyroid disorders. Therefore, the aim of the 
present study was to evaluate atrial conduction abnor-
malities and left atrial mechanical function in patients with 
subclinical thyroid disorders.
Material and methods
Study population
We studied 40 patients (32 female and eight male with 
a mean age of 42.4 ± 11.0 years) with subclinical hyper-
thyroidism and 40 patients (33 female and seven male 
with a mean age of 38.6 ± 11.5 years) with subclinical 
hypothyroidism who were newly diagnosed and un-
treated, or previously diagnosed patients. The study 
patients had normal sinus rhythm and narrow QRS 
complex on electrocardiography (ECG). In addition, 
40 healthy control subjects (32 female and eight male 
with a mean age of 42.0 ± 5.1 years) were included. The 
diagnosis of subclinical hyperthyroidism was reached 
with decreased serum TSH (< 0.1 uIU/mL) and normal 
free T4 (fT4) levels in fasting blood samples (normal 
values in our laboratory were 0.4–4.0 mU/L for TSH 
and 0.9–1.9 ng/mL for fT4). The diagnosis of subclinical 
hypothyroidism was reached with increased serum TSH 
(> 4.0mU/L) and normal free T4 (fT4) levels in fasting 
blood samples (normal values in our laboratory were 
0.4–4.0 mU/L for TSH and 0.9–1.9 ng/mL for fT4). The 
entire study population’s demographic characteristics, 
biochemical parameters, lipid values and ECGs were 
obtained. Exclusion criteria were as follows: overt hy-
pothyroidism or hyperthyroidism, acute coronary syn-
drome, prior myocardial infarction and coronary artery 
disease, congestive heart failure, left ventricular (LV) 
hypertrophy, prolonged QRS duration (≥ 120 msn), re-
duced LV ejection fraction (< 55%), chronic obstructive 
pulmonary disease, significant valvular heart disease, 
pacemaker implantation, atrial flutter or fibrillation, 
frequent ventricular pre-excitation and atrio-ventricular 
conduction abnormalities, hypertension (resting blood 
pressure ≥ 140/90 mm Hg), diabetes mellitus, medica-
tions known to alter cardiac conduction, peripheral 
vascular diseases, pulmonary or neurological disease, 
pericarditis, congenital heart disease, alcohol abuse, 
renal or hepatic disease and poor echocardiographic 
imaging. Approval for the study was obtained from 
the local ethics committee. All subjects included in the 
study signed informed consent after careful explanation 
of the study procedures.
Electrocardiography
At study entry, all subjects underwent standard 12-lead 
ECG, acquired using the MAC 5500 electrocardiograph 
(GE Healthcare, Milan, Italy) at a paper speed of 50 mm/s 
and 20 mm/mV. All recordings were performed in the 
same quiet room through spontaneous breathing, 
with a subsequent 20 minutes of adjustment in the 
supine position. P wave duration measurements were 
performed manually by two of the observers using 
calipers and a magnifying lens for the exact definition 
of the ECG deflection, as defined in a previous study 
[20]. The beginning of the P wave was defined as the 
point where the initial deflection of the P wave crossed 
the iso-electric line, and the end of the P wave was 
defined as the point where the final deflection of the 
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P wave crossed the iso-electric line. ECG recordings 
with measurable P waves in fewer than ten leads were 
excluded from the analysis. The difference between 
P wave maximum and P wave minimum durations was 
defined as P wave dispersion [20, 21]. Intra-observer 
and inter-observer mean percent mistake (absolute dif-
ference between two observations divided by the mean 
and expressed in percent) for maximum and minimum 
P wave duration measurements were determined in 
50 randomly selected study applicants (30 patients/20 
controls) and were < 5% for p maximum and < 6% for 
p minimum.
Standard echocardiography
All patients were evaluated by transthoracic M mode, 
two dimensional (2D), pulsed-wave (PW), continuous 
wave (CW), colour flow and tissue Doppler imaging 
(TDI). All examinations were performed with the GE 
Vivid-7 system (GE Vingmed, Horten, Norway) with 
a 2–4 MHz transducer at a depth of 16 cm. During echo-
cardiography, a continuous single-lead ECG recording 
was obtained. All patients were imaged in the left lat-
eral decubitus position. 2D and conventional Doppler 
examinations were obtained in the parasternal and api-
cal views, according to the guidelines of the American 
Society of Echocardiography [21]. LV diameters and 
wall thickness were measured by M-mode echocardio- 
graphy. LV ejection fraction was calculated using apical 
two-and four-chamber views by Simpson’s method, 
according to the American Society of Echocardiography 
guidelines [21]. The mitral valve inflow pattern (E-wave, 
A-wave, E-wave deceleration time [Dt], E/A ratio and 
isovolumic relaxation time [IVRT]) was measured using 
pulsed wave Doppler. LV mass index was calculated 
using the formula with the Deveraux equation [22]. LA 
volumes were obtained via apical four-chamber views 
by a disc method [21, 23]. LA maximum volume (Vmax) 
at the end-systolic phase, LA minimum volume (Vmin) 
at the end-diastolic phase, and LA volume before atrial 
systole (Vp) were measured and calculated indexed to 
body surface area. The LA function parameters were 
calculated as follows:
 — LA passive emptying volume = Vmax – Vp;
 — LA passive emptying fraction = [(Vmax – Vp)/ 
/Vmax] × 100%;
 — LA active emptying volume = Vp – Vmin;
 — LA active emptying fraction = [(Vp – Vmin)/ 
/Vp] × 100% [17].
Tissue Doppler echocardiography
TDI was performed by transducer frequencies of 3.5 to 
4.0 MHz, adjusting the spectral pulsed Doppler signal 
filters to acquire the Nyquist limit of 15 to 20 cm/s and 
using the minimal optimal gain. Myocardial TDI ve-
locities (peak systolic [Sm], early diastolic [Em] and late 
diastolic velocities [Am]) were measured via spectral 
pulsed Doppler as of the LV-free wall from the apical 
four-chamber view [21]. The ultrasound beam was 
positioned as parallel as possible with the myocardial 
segment to acquire the optimal angle of imaging. The 
time interval from the P wave onset on the surface 
ECG to the beginning of the late diastolic wave (Am), 
which is defined as atrial electromechanical coupling 
(PA), was obtained from lateral mitral annulus, septal 
mitral annulus, and right ventricular tricuspid annulus 
and named as PA lateral, PA septum, and PA tricuspid, 
respectively. The difference between PA lateral and PA 
tricuspid was defined as inter-atrial electromechanical 
delay (EMD), and the difference between PA lateral 
and septum was defined as intra-atrial EMD [20, 21]. All 
measurements were repeated three times, and average 
values were received for each of the atrial conduction 
delay times. All measurements were performed by two 
experienced investigators unaware of the subject’s clini-
cal status. If a difference of > 5% in any of the variables 
measured by both investigators was found, the patient 
was not included, whereas if the difference was < 5%, 
the measurements were averaged.
Statistical analysis
All analyses were performed using the SPSS (SPSS for 
Windows 15.0) software package. Continuous variables 
were presented as mean ± standard deviation. Categori-
cal variables were presented as the percentage. All the nu-
merical variables of the study groups presented a normal 
distribution, and the variances between the groups were 
equal. Thus, one-way analyses of variance (ANOVA) for 
mean and post hoc Tukey test were used for individual 
group differences for the comparison of groups. The 
relationships between variables were examined with 
Pearson and Spearman correlation coefficients. Linear 
multivariate regression analysis was used to recognise 
the significant determinants of interatrial delay, which 
incorporated variables that correlated with a P value of 
less than 0.1 in the correlation analysis. A value of p < 0.05 
was considered statistically significant.
Results
Patient characteristics
The baseline demographic and biochemical parameters 
of the three groups are set out in Table I. All groups had 
similar demographic findings such as age, sex, body 
mass index (BMI), body surface area (BSA), smoking, 
heart rate, systolic and diastolic blood pressure and lipid 
levels (p > 0.05). Unsurprisingly, patients with subclini-
cal hypothyroidism had significantly higher TSH and 
significantly lower fT4 (p < 0.001 and p < 0.001 respec-
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tively). The patients with subclinical hyperthyroidism 
had significantly lower TSH and significantly higher 
fT4 (p < 0.001 and p < 0.001 respectively). All groups 
were similar in terms of conventional and Doppler echo-
cardiographic parameters. Only peak systolic velocity 
(Sm) and early diastolic velocity (Em) were significantly 
lower in patients with subclinical hypothyroidism, and 
subclinical hyperthyroid patients on TDI compared to 
controls (p = 0.027 and p = 0.001 respectively, Table II).
Atrial conduction parameters
Atrial electromechanical time intervals and P wave 
analysis are set out in Table III. The PA lateral and sep-
tal durations were significantly higher in patients with 
subclinical thyroid disorders than the control group, 
but there was no difference in PA tricuspid duration 
between the groups. Intra- and interatrial EMD were 
significantly higher in patients with subclinical thy-
roid disorders than the control group. P wave disper-
sion (PWD) was significantly higher in patients with 
subclinical thyroid disorders than the control group. 
There was no correlation between PWD and TSH. PA 
lateral and interatrial delay were positively correlated 
with TSH (r = 0.507, p = 0.006 and r = 0.455, p = 0.015, 
respectively, Figure I) in subclinical hypothyroid pa-
tients. There was a negative correlation between TSH 
and interatrial delay (r = –0.492, p = 0.006, Figure II) in 
subclinical hyperthyroid patients.
Left atrial mechanical function
LA volume measurements and mechanical functions are 
set out in Table IV. Both groups were similar in terms of 
Vmax, Vmin and Vp (p = 0.292, p = 0.257 and p = 0.242 re-
spectively). However, LA passive emptying volume and 
LA passive emptying fraction were significantly decreased 
in patients with subclinical thyroid disorders. Moreover, 
LA active emptying volume and LA active emptying 
fraction were significantly increased in patients with 
subclinical thyroid disorders. There was positive correla-
tion only between LA active emptying volume and TSH 
levels (r = 0.586, p = 0.001) in patients with subclinical 
thyroid disorders.
Linear multivariate regression analysis demon-
strated that TSH was the only independent factor of 
interatrial delay in patients with subclinical hypothy-
roidism and subclinical hyperthyroidism (R² = 0.207, 
b = 0.455, p = 0.015 and R² = 0.242, b = –0.492, p = 0.006, 
respectively).
Table I. Baseline demographic and biochemical characteristics of the groups
Tabela I. Wyjściowa charakterystyka demograficzna i biochemiczna badanych grup
Parameter Subclinical hypothyroid 
n = 40
Subclinical hyperthyroid 
n = 40
Control 
n = 40
p value
Age 38.6 ± 11.5 42.4 ± 11.0 42.0 ± 10.1 0.226
Gender (female, %) 32 (80.0%) 33 (82.5%) 32 (80.0%) 0.701
Smoking 9 (22.5%) 8 (20.0%) 10 (25.0%) 0.386
BMI [kg/m2] 27.4 ± 4.6 27.3 ± 4.5 28.3 ± 5.1 0.517
BSA 1.80 ± 0.16 1.77 ± 0.19 1.86 ± 0.17 0.111
Heart rate [beats/min] 74.6 ± 10.6 75.2 ± 9.8 74.6 ± 9.0 0.869
SBP [mm Hg] 117.8 ± 18.3 117.3 ± 17.4 119.1 ± 19.3 0.436
DBP [mm Hg] 77.8 ± 7.0 76.8 ± 9.0 78.1 ± 8.3 0.572
Total cholesterol [mg/dL] 186.0 ± 26.7 185.6 ± 27.6 186 ± 28.3 0.805
LDL [mg/dL] 114.7 ± 16.4 111.5 ± 17.7 111.0 ± 18.3 0.588
HDL [mg/dL] 42.3 ± 7.1 43.9 ± 7.7 42.5 ± 5.8 0.701
Triglycerides [mg/dL] 151 ± 28.2 154 ± 29.0 152 ± 29.1 0.964
Glucose 95.6 ± 7.1 95.5 ± 12.2 97.9 ± 14.2 0.547
Haemoglobin [g/dL] 13.4 ± 3.2 13.5 ± 2.7 13.1 ± 2.8 0.692
Creatinine [mg/dL] 0.79 ± 0.18 0.81 ± 0.14 0.77 ± 0.16 0.217
TSH [uIU/mL] 8.6 ± 4.9 0.06 ± 0.09 2.0 ± 0.8 < 0.001
Free T3 [pg/mL] 2.9 ± .71 4.01 ± 0.87 3.4 ± 0.83 0.492
Free T4 [ng/dL] 0.97 ± 0.12 1.46 ± 0.23 1.25 ± 0.20 < 0.001
BMI — body mass index; BSA — body surface area; SBP — systolic blood pressure; DBP — diastolic blood pressure; LDL — low-density lipoprotein; 
HDL — high-density lipoprotein; TSH — thyroid-stimulating hormone 
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Discussion
The objective of this study was to analyse the changes 
of atrial functions in patients with subclinical thyroid 
disorders. We demonstrated significantly impaired 
left atrial functions in patients with subclinical thyroid 
disorders. Furthermore, atrial conduction parameters 
were significantly prolonged in patients with subclini-
cal thyroid disorders compared to the control group. 
Additionally, we found that TSH level was the only 
independent factor of interatrial delay in patients with 
subclinical thyroid disorders.
Table II. Echocardiographic charactheristics of groups
Tabela II. Charakterystyka echokardiograficzna badanych grup
Parameter Subclinical 
hypothyroid 
n = 40
Subclinical 
hyperthyroid 
n = 40
Control 
n = 40
p value
LVESD [mm] 30.0 ± 3.5 29.9 ± 3.1 30.1 ± 4.1 0.930
LVEDD [mm] 48.2 ± 5.5 47.0 ± 5.1 47.2 ± 4.2 0.341
LVESV [mL] 27.7 ± 8.0 28.1 ± 8.7 27.1 ± 5.3 0.868
LVEDV [mL] 82.7 ± 16.2 90.4 ± 18.4 85.4 ± 18.0 0.177
IVS [mm] 10.1 ± 1.7 9.8 ± 19 9.5 ± 1.5 0.216
PW [mm] 9.5 ± 1.2 9.5 ± 1.4 9.2 ± 1.0 0.709
LA [mm] 35.0 ± 8.7 35.3 ± 7.1 32.3 ± 6.1 0.180
E [cm/s] 77.8 ± 27.0 76.8 ± 19.0 78.1 ± 18.3 0.572
A [cm/s] 66.0 ± 26.7 65.6 ± 27.6 59.6 ± 22.3 0.305
DT [ms] 216.7 ± 36.4 215.5 ± 37.7 211.0 ± 38.3 0.788
IVRT [ms] 90.3 ± 27.1 88.9 ± 27.7 87.5 ± 25.8 0.701
LV mass index 84.4 ± 18.2 83.9 ± 19.0 83.2 ± 19.1 0.461
LVEF [%] 64.0 ± 18.2 64.2 ± 19.0 64.4 ± 19.1 0.811
Sm [cm/s] 10.8 ± 2.2 11.3 ± 1.8 12.3 ± 2.2 0.027
Em [cm/s] 11.4 ± 2.2 11.5 ± 2.5 13.4 ± 1.9 0.001
Am [cm/s] 13.6 ± 3.1 13.1 ± 2.7 12.8 ± 2.4 0.653
LVESD — left ventricular end-systolic diameter; LVEDD — left ventricular end diastolic diameter; LVESV — left ventricular end systolic volume;  
LVEDV — left ventricular end diastolic volume; IVS — interventricular septum; PW — posterior wall; LA — left atrium; E — early diastolic mitral inflow 
velocity; A — late diastolic mitral inflow velocity; DT — deceleration time; IVRT — isovolumetric relaxation time; LVEF — left ventricular ejection 
fraction; Sm — peak systolic mitral annular velocity; Em — early diastolic mitral annular velocity; Am — late diastolic mitral annular velocity
Table III. Comparison of parameters of atrial conduction times and P wave dispersion between the groups
Tabela III. Porównanie parametrów czasu przewodzenia przedsionkowego i dyspersji załamka P między grupami
Subclinical hypothyroid Subclinical hyperthyroid Control p value
PA lateral [ms] 67.3 ± 18.9 66.9 ± 15.1 55.8 ± 12.4 < 0.001
PA septum [ms] 49.9 ± 13.2 50.2 ± 13.1 44.2 ± 7.2 < 0.001
PA tricuspid [ms] 39.1 ± 5.4 39.3 ± 4.7 37.7 ± 5.3 0.112
PA lateral-PA tricuspid [ms]* 26.5 ± 5.4 26.0 ± 9.9 18.4 ± 8.0 < 0.001
PA septum-PA tricuspid [ms]# 8.9 ± 4.0 9.5 ± 4.7 6.7 ± 3.3 0.001
Max P-wave duration [ms] 102.7 ± 25.3 98.5 ± 24.5 95.3 ± 18.9 0.090
Min P-wave duration [ms] 56.7 ± 11.0 55.0 ± 9.9 55.3 ± 9.7 0.383
P-wave dispersion [ms] 46.0 ± 6.9 43.5 ± 8.3 40.0 ± 8.7 0.026
PA — interval with tissue Doppler imaging from the onset of p wave on the surface electrocardiogram to beginning of the late diastolic wave (Am 
wave); *inter-atrial electromechanical delay; #intra-atrial electromechanical delay
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Table IV. Measurements of left atrial mechanical functions
Tabela IV. Pomiary czynności mechanicznej lewego przedsionka
Parameter Subclinical hypothyroid Subclinical hyperthyroid Control group p value
Vmax [mL/m2] 28.7 ± 8.0 28.2 ± 7.8 27.4 ± 8.8 0.292
Vmin [mL/m2] 8.4 ± 3.2 9.9 ± 4.2 7.8 ± 3.7 0.257
Vp [mL/m2] 15.9 ± 5.5 17.3 ± 6.1 15.1 ± 5.9 0.242
LA passive emptying 
volume [mL/m2]
10.3 ± 3.7 10.7 ± 4.6 14.1 ± 3.9 0.001
LA passive emptying 
fraction [%]
38.7 ± 9.9 37.2 ± 9.2 49.3 ± 12.9 <0.001
LA active emptying 
volume [mL/m2]
7.9 ± 3.5 8.1 ± 2.7 6.3 ± 2.5 0.006
LA active emptying 
fraction [%]
48.7 ± 9.9 46.3 ± 8.4 40.5 ± 9.7 0.001
LA — left atrium; Vmax — LA maximum volume; Vmin — LA minimum volume; Vp — LA volume before P wave
Figure 2. Negative correlation between TSH levels and interatrial 
delay in patients with subclinical hyperthyroidism
Rycina 2. Ujemne korelacje między stężeniami TSH i opóźnieniem 
przewodzenia międzyprzedsionkowego u chorych z subkliniczną 
nadczynnością tarczycy
Figure 1. Positive correlation between TSH levels and interatrial 
delay in patients with subclinical hypothyroidism
Rycina 1. Dodatnie korelacje między stężeniami TSH i opóźnieniem 
przewodzenia międzyprzedsionkowego u chorych z subkliniczną 
niedoczynnością tarczycy
The myocardium is well-known among tissues that 
include thyroid hormone receptors [10]. Thyroid hor-
mone deficiency can alter cardiac muscle function by 
decreasing the activity of several enzymes involved in 
the regulation of myocyte calcium fluxes [10] and the 
expression of several contractile proteins [24]. In addi-
tion, thyroid hormone has been shown to affect calcium 
uptake by the sarcoplasmic reticulum, to stimulate 
plasma membrane Ca-ATPase activity. and to increase 
voltage-dependent channels in animal ventricular cells 
[10, 24, 25]. Subclinical thyroid disorders are defined as 
an asymptomatic state characterised by normal serum 
concentration of fT4 and increased or decreased serum 
concentrations of TSH. Thus, it may seem surprising 
to find cardiac alterations similar to those observed in 
overt thyroid disorders. However, minute decrements 
in hormone synthesis may over time lead to biochemi-
cal and functional signs that are qualitatively similar to 
those of thyroid disorders. The most consistent cardiac 
abnormalities recognised in subclinical hyperthyroid 
patients are increased heart rate and enhanced LV 
mass [12, 26]. However, in our study, LV mass index 
was similar in all groups because the study population 
consisted of young patients. Di Bello et al. [27] inves-
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tigated and reported early systolic hyperdeformability 
and hypercontractility together with impaired diastolic 
function by strain echocardiography in patients with 
subclinical hyperthyroidism. They speculated that the 
direct effect of thyroid hormones on the heart may cause 
these results. Galetta et al. [28] demonstrated increased 
sympathetic activity and increased inhomogeneity of 
ventricular recovery times in subclinical hyperthyroid 
patients. Another study demonstrated a significant in-
crease in serum levels of NT-pro-BNP in patients with 
overt and subclinical hyperthyroidism [29]. Addition-
ally, our results suggested prolonged atrial conduction 
times and impaired left atrial mechanical functions in 
subclinical hyperthyroid patients. Subclinical hyper-
thyroidism could cause many significant effects on the 
cardiovascular system. It has been related to higher 
heart rate and higher risk of supraventricular arrhyth-
mias [28–31]. Previous studies also showed the effect of 
prolonged atrial electromechanical coupling interval 
and impaired atrial functions on the development of su-
praventricular arrhythmias [19, 20]. We thought that our 
results may explain an increased risk for development 
of arrhythmias in subclinical hyperthyroid patients.
On the other hand, thyroid hormones also affect the 
transcription of structural and regulatory proteins on the 
cardiovascular system [2]. Also, mild changes in blood 
levels of thyroid hormones have many adverse effects on 
both the function and structure of the heart. These effects 
are decreased cardiac contractility and cardiac output, car-
diomyocyte atrophy [1–4], myocardial fibrosis and the de-
velopment of heart failure [32, 33]. Aghini-Lombardi et al. 
[34] demonstrated early functional and textural alterations 
in subclinical hypothyroid patients using intra-myocardial 
ultrasonic video-densitometry analysis. Additionally, 
our study suggests prolonged atrial electromechanical 
coupling interval and impaired left atrial functions in sub-
clinical hypothyroid patients. The increased myocardial 
fibrosis and cardiomyocyte atrophy could be considered 
as causes of impaired atrial functions in subclinical hypo-
thyroid patients.
Study limitations
The major limitation of our study is its cross-sectional 
design and lack of follow-up of the patients. Another 
limitation is the relatively small study population. 
Patients could not be followed-up prospectively for ar-
rhythmic episodes. Therefore, we do not know whether 
prolongation of intra- and interatrial EMD and impaired 
LA mechanical functions predict arrhythmias and heart 
failure in subclinical thyroid disorders. For these rea-
sons, long-term follow-up and large-scale prospective 
studies are needed to determine the predictive value of 
prolonged intra- and interatrial EMD and LA mechani-
cal functions in this population.
Conclusions
The current study is the first to report impaired LA 
mechanical and electromechanical function in patients 
with subclinical thyroid disorders. Secondly, impaired 
atrial mechanical function and atrial electromechanical 
coupling interval were related to TSH levels. Finally, 
interatrial electromechanical delay was increased in 
subclinical thyroid disorders, and TSH is an indepen- 
dent determinant of interatrial electromechanical delay. 
Prolonged atrial electromechanical coupling time and 
impaired mechanical atrial functions may be related to 
the increased incidence of arrhythmias and heart failure 
in subclinical thyroid disorders. In the light of these 
results, we emphasise that subclinical thyroid disorders 
should be carefully followed up and treated with the 
same thoroughness as clinical thyroid disorders.
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